FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Richard Foster

Research Profile

Disorders

Procedures

Anatomy

Retroperitoneal Space

Concepts & Ideas

Co-author Network

Publications

TOP 3
K Clint Cary; Stephen D W Beck; Richard Bihrle; Richard S Foster
Clinical and pathological features predictive of nephrectomy at post-chemotherapy retroperitoneal lymph node dissection.
Yaron Ehrlich; Stephen D W Beck; Richard Bihrle; Richard S Foster; Lawrence H Einhorn
Serum tumor markers in testicular cancer.
Jennifer B Kum; Thomas M Ulbright; Mingsheng Wang; Sean R Williamson; Shaobo Zhang; Stephen D W Beck; John N Eble; Richard S Foster; David J Grignon; Liang Cheng
Molecular genetic evidence supporting the origin of somatic-type malignancy and teratoma from the same progenitor cell.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Richard Foster (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: K Clint Cary; Stephen D W Beck; Richard Bihrle; Richard S Foster
Clinical and pathological features predictive of nephrectomy at post-chemotherapy retroperitoneal lymph node dissection.
The Journal of urology 2013;189(3):812-7.
2013: Yaron Ehrlich; Stephen D W Beck; Richard Bihrle; Richard S Foster; Lawrence H Einhorn
Serum tumor markers in testicular cancer.
Urologic oncology 2013;31(1):17-23.
2012: Jennifer B Kum; Thomas M Ulbright; Mingsheng Wang; Sean R Williamson; Shaobo Zhang; Stephen D W Beck; John N Eble; Richard S Foster; David J Grignon; Liang Cheng
Molecular genetic evidence supporting the origin of somatic-type malignancy and teratoma from the same progenitor cell.
The American journal of surgical pathology 2012;36(12):1849-56.
2012: Liang Cheng; John N Eble; Richard S Foster; Mingsheng Wang; Shaobo Zhang; Stephen D W Beck; Thomas M Ulbright
Molecular genetic evidence supporting the neoplastic nature of fibrous stroma in testicular teratoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012;25(10):1432-8.
2011: Richard S Foster
Role of urologist in testis cancer management.
The Journal of urology 2011;186(6):2151.
2011: Michael C Risk; Richard S Foster
Postchemotherapy retroperitoneal lymph node dissection for testis cancer.
Expert review of anticancer therapy 2011;11(1):95-106.
2010: Niels-Erik B Jacobsen; Stephen D W Beck; Lewis E Jacobson; Richard Bihrle; Lawrence H Einhorn; Richard S Foster
Is retroperitoneal histology predictive of liver histology at concurrent post-chemotherapy retroperitoneal lymph node dissection and hepatic resection?
The Journal of urology 2010;184(3):949-53.
2010: Yaron Ehrlich; Richard S Foster; Richard Bihrle; Liang Cheng; Yan Tong; Michael O Koch
Division of prostatic anterior fibromuscular stroma reduces urethral resistance in an ex vivo human prostate model.
Urology 2010;76(2):511.e10-3.
2010: Thomas M Ulbright; Eyas M Hattab; Shaobo Zhang; Yaron Ehrlich; Richard S Foster; Lawrence H Einhorn; Liang Cheng
Primitive neuroectodermal tumors in patients with testicular germ cell tumors usually resemble pediatric-type central nervous system embryonal neoplasms and lack chromosome 22 rearrangements.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2010;23(7):972-80.
2010: Clint D Bahler; Richard S Foster; Richard Bihrle; Stephen D W Beck; Thomas A Gardner; Chandru P Sundaram; Timothy A Masterson; Liang Cheng; Michael O Koch
Radical prostatectomy as initial monotherapy for patients with pathologically confirmed high-grade prostate cancer.
BJU international 2010;105(10):1372-6.
2010: Yaron Ehrlich; Mary J Brames; Stephen D W Beck; Richard S Foster; Lawrence H Einhorn
Long-term follow-up of Cisplatin combination chemotherapy in patients with disseminated nonseminomatous germ cell tumors: is a postchemotherapy retroperitoneal lymph node dissection needed after complete remission?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(4):531-6.
2009: Richard S Foster
Editorial comment.
The Journal of urology 2009;182(5):2310.
2009: Jessica A Clevenger; Richard S Foster; Thomas M Ulbright
Differentiated rhabdomyomatous tumors after chemotherapy for metastatic testicular germ-cell tumors: a clinicopathological study of seven cases mandating separation from rhabdomyosarcoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(10):1361-6.
2009: Stephen D W Beck; Richard S Foster
Management of the post chemotherapy subcentimeter residual mass: the case for observation.
World journal of urology 2009;27(4):485-8.
2009: Stanton M Regan; Stephen D Beck; Richard Bihrle; Richard S Foster
Role of routine stentograms following urinary diversion in modern practice.
The Canadian journal of urology 2009;16(3):4660-3.
2009: Xiaoyan Wang; Shaobo Zhang; Gregory T MacLennan; Katharina Biermann; Richard S Foster; Stephen D W Beck; Liang Cheng
Epidermal growth factor receptor protein expression and gene amplification in the chemorefractory metastatic embryonal carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2009;22(1):7-12.
2008: James A Brown; Richard Bihrle; Richard S Foster
Delayed orchiectomy at postchemotherapy retroperitoneal lymph node dissection due to laterality of retroperitoneal metastatic pattern consistent with testicular primary: assessment of pathologic findings.
Urology 2008;71(5):911-4.
2007: Liang Cheng; Shaobo Zhang; Mingsheng Wang; Darrell D Davidson; M J Morton; J Huang; S Zheng; Timothy D Jones; Stephen D W Beck; Richard S Foster
Molecular genetic evidence supporting the neoplastic nature of stromal cells in 'fibrosis' after chemotherapy for testicular germ cell tumours.
The Journal of pathology 2007;213(1):65-71.
2007: Stephen D W Beck; Matthew D Peterson; Richard Bihrle; John P Donohue; Richard S Foster
Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patients.
The Journal of urology 2007;178(2):504-6; discussion 506.
2007: Stephen D W Beck; Richard S Foster; Richard Bihrle; Lawrence H Einhorn; John P Donohue
Post chemotherapy RPLND in patients with elevated markers: current concepts and clinical outcome.
The Urologic clinics of North America 2007;34(2):219-25; abstract ix-x.
2007: Stephen D W Beck; Richard S Foster; Richard Bihrle; John P Donohue
Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
Urology 2007;69(3):557-9.
2007: Stephen D W Beck; Liang Cheng; Richard Bihrle; John P Donohue; Richard S Foster
Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy?
The Journal of urology 2007;177(3):944-6.
2007: Niels-Erik B Jacobsen; Richard S Foster; John P Donohue
Retroperitoneal lymph node dissection in testicular cancer.
Surgical oncology clinics of North America 2007;16(1):199-220.
2006: Liang Cheng; Shaobo Zhang; Gregory T MacLennan; Christopher K Poulos; Ming-Tse Sung; Stephen D W Beck; Richard S Foster
Interphase fluorescence in situ hybridization analysis of chromosome 12p abnormalities is useful for distinguishing epidermoid cysts of the testis from pure mature teratoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(19):5668-72.
2006: Timothy D Jones; Mingsheng Wang; Ming-Tse Sung; Shaobo Zhang; Thomas M Ulbright; John N Eble; Stephen D W Beck; Richard S Foster; John J Anagnostou; Clay Conner; Liang Cheng
Clonal origin of metastatic testicular teratomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(18):5377-83.
2006: Ming-Tse Sung; Timothy D Jones; Stephen D W Beck; Richard S Foster; Liang Cheng
OCT4 is superior to CD30 in the diagnosis of metastatic embryonal carcinomas after chemotherapy.
Human pathology 2006;37(6):662-7.
2005: Stephen D W Beck; Richard S Foster; Richard Bihrle; Lawrence H Einhorn; John P Donohue
Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer.
Urologic oncology 2005;23(6):423-30.
2005: Stephen D W Beck; Richard S Foster; Richard Bihrle; Lawrence H Einhorn; John P Donohue
Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):6149-56.
2005: Liang Cheng; Michael O Koch; Beth E Juliar; Joanne Daggy; Richard S Foster; Richard Bihrle; Thomas A Gardner
The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(13):2911-7.
2004: Richard S Foster
Modified retroperitoneal lymphadenectomy.
BJU international 2004;94(6):941-55.
2004: Thomas M Ulbright; John D Henley; Oscar W Cummings; Richard S Foster; Liang Cheng
Cystic trophoblastic tumor: a nonaggressive lesion in postchemotherapy resections of patients with testicular germ cell tumors.
The American journal of surgical pathology 2004;28(9):1212-6.
2004: Robert E Emerson; Thomas M Ulbright; Shaobo Zhang; Richard S Foster; John N Eble; Liang Cheng
Nephroblastoma arising in a germ cell tumor of testicular origin.
The American journal of surgical pathology 2004;28(5):687-92.
2004: Ashraf A Mosharafa; Richard S Foster; Michael O Koch; Richard Bihrle; John P Donohue
Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer.
The Journal of urology 2004;171(5):1839-41.
2004: Richard S Foster; Stephen Beck; Richard Bihrle
Secondary surgery in germ cell tumors--when and how extensively should it be performed?
World journal of urology 2004;22(1):37-40.
2004: Ashraf A Mosharafa; Richard S Foster; Bradley C Leibovich; Thomas M Ulbright; Richard Bihrle; Lawrence H Einhorn; John P Donohue
Histology in mixed germ cell tumors. Is there a favorite pairing?
The Journal of urology 2004;171(4):1471-3.
2003: Kevin M Kernek; Thomas M Ulbright; Shaobo Zhang; Steven D Billings; Oscar W Cummings; John D Henley; Helen Michael; Matteo Brunelli; Guido Martignoni; Richard S Foster; John N Eble; Liang Cheng
Identical allelic losses in mature teratoma and other histologic components of malignant mixed germ cell tumors of the testis.
The American journal of pathology 2003;163(6):2477-84.
2003: Ryan F Paterson; Thomas M Ulbright; Gregory T MacLennan; Shaobo Zhang; Chong-Xian Pan; Christopher J Sweeney; Curtiss R Moore; Richard S Foster; Michael O Koch; John N Eble; Liang Cheng
Molecular genetic alterations in the laser-capture-microdissected stroma adjacent to bladder carcinoma.
Cancer 2003;98(9):1830-6.
2003: Francis D Sheski; John D Henley; Richard S Foster; Lawrence H Einhorn
Prostate carcinoma presenting as multiple pulmonary nodules in an asymptomatic patient with a history of testicular nonseminomatous germ cell tumor.
Urology 2003;62(4):748.
2003: David W Brandli; Thomas M Ulbright; Richard S Foster; Oscar W Cummings; Shaobo Zhang; Christopher J Sweeney; John N Eble; Liang Cheng
Stroma adjacent to metastatic mature teratoma after chemotherapy for testicular germ cell tumors is derived from the same progenitor cells as the teratoma.
Cancer research 2003;63(18):6063-8.
2003: Ashraf A Mosharafa; Richard S Foster; Richard Bihrle; Michael O Koch; Thomas M Ulbright; Lawrence H Einhorn; John P Donohue
Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors?
Cancer 2003;98(4):753-7.
2003: David W Brandli; Michael O Koch; Richard S Foster; Richard Bihrle; Thomas A Gardner
Biochemical disease-free survival in patients with a high prostate-specific antigen level (20-100 ng/mL) and clinically localized prostate cancer after radical prostatectomy.
BJU international 2003;92(1):19-22; discussion 22-3.
2003: Cheryl Younger; Thomas M Ulbright; Shaobo Zhang; Steven D Billings; Oscar W Cummings; Richard S Foster; John N Eble; Liang Cheng
Molecular evidence supporting the neoplastic nature of some epidermoid cysts of the testis.
Archives of pathology & laboratory medicine 2003;127(7):858-60.
2003: Michael O Koch; Anish H Nayee; James Sloan; Thomas Gardner; Gregory R Wahle; Richard Bihrle; Richard S Foster
Early catheter removal after radical retropubic prostatectomy: long-term followup.
The Journal of urology 2003;169(6):2170-2.
2003: Ashraf A Mosharafa; Richard S Foster; Bradley C Leibovich; Richard Bihrle; Cynthia Johnson; John P Donohue
Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?
The Journal of urology 2003;169(6):2126-8.
2003: Heng Hong; Michael O Koch; Richard S Foster; Richard Bihrle; Thomas A Gardner; Joanne Daggy; Thomas M Ulbright; John N Eble; Liang Cheng
Anatomic distribution of periprostatic adipose tissue: a mapping study of 100 radical prostatectomy specimens.
Cancer 2003;97(7):1639-43.
2002: Stephen D W Beck; Richard S Foster; Richard Bihrle; Thomas M Ulbright; Michael O Koch; Gregory R Wahle; Lawrence H Einhorn; John P Donohue
Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer.
The Journal of urology 2002;168(4 Pt 1):1402-4.
2001: Trevor M Soergel; Michael O Koch; Richard S Foster; Richard Bihrle; Gregory R Wahle; Thomas Gardner; S H Jung
Accuracy of predicting long-term prostate specific antigen outcome based on early prostate specific antigen recurrence results after radical prostatectomy.
The Journal of urology 2001;166(6):2198-201.
2001: Richard S Foster
Early-stage testis cancer.
Current treatment options in oncology 2001;2(5):413-9.
2001: Stephen D W Beck; Richard S Foster; Richard Bihrle; Michael O Koch; Gregory R Wahle; John P Donohue
Aortic replacement during post-chemotherapy retroperitoneal lymph node dissection.
The Journal of urology 2001;165(5):1517-20.
2001: Kent A Robertson; H A Bullock; Yi Xu; R Tritt; E Zimmerman; Thomas M Ulbright; Richard S Foster; Lawrence H Einhorn; Mark R Kelley
Altered expression of Ape1/ref-1 in germ cell tumors and overexpression in NT2 cells confers resistance to bleomycin and radiation.
Cancer research 2001;61(5):2220-5.
2000: Richard S Foster; BP Hermans; Richard Bihrle; John P Donohue
Clinical stage I pure yolk sac tumor of the testis in adults has different clinical behavior than juvenile yolk sac tumor.
The Journal of urology 2000;164(6):1943-4.
2000: Michael O Koch; Richard S Foster; B Bell; S Beck; Liang Cheng; Dipen J Parekh; S H Jung
Characterization and predictors of prostate specific antigen progression rates after radical retropubic prostatectomy.
The Journal of urology 2000;164(3 Pt 1):749-53.
2000: BP Hermans; Christopher J Sweeney; Richard S Foster; L E Einhorn; John P Donohue
Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection.
The Journal of urology 2000;163(6):1721-4.
2000: Stephen D W Beck; Thomas M Ulbright; Richard S Foster
A benign para-aortic lymph node of histologically proved follicular hyperplasia mimicking metastatic germ cell cancer.
The Journal of urology 2000;163(5):1520-1.
2000: Helen Michael; J Lucia; Richard S Foster; Thomas M Ulbright
The pathology of late recurrence of testicular germ cell tumors.
The American journal of surgical pathology 2000;24(2):257-73.
2000: Christopher J Sweeney; BP Hermans; Douglas K Heilman; Richard S Foster; John P Donohue; Lawrence H Einhorn
Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma--predominant testis cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(2):358-62.
1999: Teresa Anne Smolarek; RI Blough; Richard S Foster; Thomas M Ulbright; CG Palmer; Nyla A Heerema
Cytogenetic analyses of 85 testicular germ cell tumors: comparison of postchemotherapy and untreated tumors.
Cancer genetics and cytogenetics 1999;108(1):57-69.
1998: BP Hermans; Richard S Foster; Richard Bihrle; S Little; Alan B Sandler; Lawrence H Einhorn; John P Donohue
Is retroperitoneal lymph node dissection necessary for adult paratesticular rhabdomyosarcoma?
The Journal of urology 1998;160(6 Pt 1):2074-7.
1998: Helen Michael; MT Hull; Richard S Foster; Christopher J Sweeney; Thomas M Ulbright
Nephroblastoma-like tumors in patients with testicular germ cell tumors.
The American journal of surgical pathology 1998;22(9):1107-14.
1998: Richard S Foster; John P Donohue
Can retroperitoneal lymphadenectomy be omitted in some patients after chemotherapy?
The Urologic clinics of North America 1998;25(3):479-84.
1998: John P Donohue; Richard S Foster
Retroperitoneal lymphadenectomy in staging and treatment. The development of nerve-sparing techniques.
The Urologic clinics of North America 1998;25(3):461-8.
1998: CL Coogan; Richard S Foster; G R Simmons; PG Tognoni; B J Roth; John P Donohue
Bilateral testicular tumors: management and outcome in 21 patients.
Cancer 1998;83(3):547-52.
1998: PG Tognoni; Richard S Foster; P McGraw; Douglas K Heilman; Richard Bihrle; R G Rowland; Gregory R Wahle; Lawrence H Einhorn; John P Donohue; P G Tognini
Combined post-chemotherapy retroperitoneal lymph node dissection and resection of chest tumor under the same anesthetic is appropriate based on morbidity and tumor pathology.
The Journal of urology 1998;159(6):1833-5.
1998: John P Donohue; I Leviovitch; Richard S Foster; J Baniel; PG Tognoni
Integration of surgery and systemic therapy: results and principles of integration.
Seminars in urologic oncology 1998;16(2):65-71.
1998: P A Nash; I Leibovitch; Richard S Foster; Richard Bihrle; R G Rowland; John P Donohue
En bloc nephrectomy in patients undergoing post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous testis cancer: indications, implications and outcomes.
The Journal of urology 1998;159(3):707-10.
1998: I Leibovitch; Richard S Foster; K K Kopecky; P Albers; Thomas M Ulbright; John P Donohue
Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatic disease: a combined approach using quantitive immunohistochemical, histopathologic, and radiologic assessment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):261-8.
1998: RI Blough; Nyla A Heerema; P Albers; Richard S Foster
Fluorescence in situ hybridization on nuclei from paraffin-embedded tissue in low stage pure embryonal carcinoma of the testis.
The Journal of urology 1998;159(1):240-4.
1997: CL Coogan; Richard S Foster; R G Rowland; Richard Bihrle; E R Smith; Lawrence H Einhorn; B J Roth; John P Donohue
Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone.
Urology 1997;50(6):957-62.
1997: Helen Michael; MT Hull; Thomas M Ulbright; Richard S Foster; Kathy D Miller
Primitive neuroectodermal tumors arising in testicular germ cell neoplasms.
The American journal of surgical pathology 1997;21(8):896-904.
1997: CL Coogan; J S Little; Richard Bihrle; Richard S Foster
Urethral catheter removal prior to hospital discharge following radical prostatectomy.
Urology 1997;49(3):400-3.
1996: C L Coogan; M J Hejase; G R Wahle; Richard S Foster; R G Rowland; Richard Bihrle; John P Donohue
Nerve sparing post-chemotherapy retroperitoneal lymph node dissection for advanced testicular cancer.
The Journal of urology 1996;156(5):1656-8.
1996: M J Hejase; John P Donohue; Richard S Foster; Richard Bihrle; C L Coogan; R G Rowland; G R Wahle
Post-chemotherapy resection of nonseminomatous germ cell testicular tumors metastatic to the mediastinum.
The Journal of urology 1996;156(4):1345-8.
1996: P A Nash; C G Schrepferman; R G Rowland; J Young; Richard S Foster; R Birhle; John P Donohue
The impact of pre-donated autologous blood and intra-operative isovolaemic haemodilution on the outcome of transfusion in patients undergoing radical retropubic prostatectomy.
British journal of urology 1996;77(6):856-60.
1996: Richard S Foster; J Baniel; I Leibovitch; M Curran; Richard Bihrle; R Rowland; John P Donohue
Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in low stage nonseminomatous testis cancer.
The Journal of urology 1996;155(6):1943-5.
1996: I Leibovitch; J S Little; Richard S Foster; R G Rowland; Richard Bihrle; John P Donohue
Delayed orchiectomy after chemotherapy for metastatic nonseminomatous germ cell tumors.
The Journal of urology 1996;155(3):952-4.
1996: I Leibovitch; P A Nash; J S Little; Richard S Foster; John P Donohue
Spinal cord ischemia after post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell cancer.
The Journal of urology 1996;155(3):947-51.
1996: SB Saxman; Craig Nichols; Richard S Foster; J E Messemer; John P Donohue; L H Einhorn
The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
The Journal of urology 1996;155(2):587-9.
1996: Peter Albers; Thomas M Ulbright; J Albers; G A Miller; Attilio Orazi; W N Crabtree; J Baniel; T Reister; R A Sidner; Richard S Foster; John P Donohue
Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors.
The Journal of urology 1996;155(2):579-86.
1996: John P Donohue; Richard S Foster; J S Little; Patrick J Loehrer; L E Einhorn
Biology of metastases and its clinical implications: testicular germ-cell tumors.
World journal of urology 1996;14(3):197-203.
1995: Teresa Anne Smolarek; RI Blough; Richard S Foster; Thomas M Ulbright; CG Palmer; Nyla A Heerema
Identification of multiple chromosome 12 abnormalities in human testicular germ cell tumors by two-color fluorescence in situ hybridization (FISH).
Genes, chromosomes & cancer 1995;14(4):252-8.
1995: L Leibovitch; Richard S Foster; Kenyon K Kopecky; John P Donohue
Improved accuracy of computerized tomography based clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes.
The Journal of urology 1995;154(5):1759-63.
1995: J Baniel; Richard S Foster; L H Einhorn; John P Donohue
Late relapse of clinical stage I testicular cancer.
The Journal of urology 1995;154(4):1370-2.
1995: J Baniel; I Leibovitch; Richard S Foster; R G Rowland; Richard Bihrle; John P Donohue
Hyperamylasemia after post-chemotherapy retroperitoneal lymph node dissection for testis cancer.
The Journal of urology 1995;154(4):1373-5.
1995: J S Little; Richard Bihrle; Richard S Foster
Early urethral catheter removal following radical prostatectomy: a pilot study.
Urology 1995;46(3):429-31.
1995: I Leibovitch; J Baniel; Richard S Foster; John P Donohue
The clinical implications of procedural deviations during orchiectomy for nonseminomatous testis cancer.
The Journal of urology 1995;154(3):935-9.
1995: John P Donohue; J A Thornhill; Richard S Foster; R G Rowland; Richard Bihrle
Clinical stage B non-seminomatous germ cell testis cancer: the Indiana University experience (1965-1989) using routine primary retroperitoneal lymph node dissection.
European journal of cancer (Oxford, England : 1990) 1995;31A(10):1599-604.
1995: Peter Albers; Thomas M Ulbright; J Albers; G A Miller; Richard S Foster; John P Donohue
[New parameters for prediction of pathological stage in clinical stage I non-seminomatous testicular tumors].
Der Urologe. Ausg. A 1995;34(4):316-23.
1995: I Leibovitch; R G Rowland; J S Little; Richard S Foster; Richard Bihrle; John P Donohue
Cystography after radical retropubic prostatectomy: clinical implications of abnormal findings.
Urology 1995;46(1):78-80.
1995: J Baniel; B J Roth; Richard S Foster; John P Donohue
Cost and risk benefit in the management of clinical stage II nonseminomatous testicular tumors.
Cancer 1995;75(12):2897-903.
1995: I Leibovitch; Richard S Foster; J L Wass; R G Rowland; Richard Bihrle; J S Little; Kenyon K Kopecky; John P Donohue
Color Doppler flow imaging for deep venous thrombosis screening in patients undergoing pelvic lymphadenectomy and radical retropubic prostatectomy for prostatic carcinoma.
The Journal of urology 1995;153(6):1866-9.
1995: Peter Albers; Attilio Orazi; Thomas M Ulbright; G A Miller; J H Haidar; John P Donohue; Richard S Foster
Prognostic significance of immunohistochemical proliferation markers (Ki-67/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation, and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1995;8(5):492-7.
1995: Peter Albers; Richard S Foster; Richard Bihrle; Mark C Adams; MA Keating
Ectopic ureters and ureteroceles in adults.
Urology 1995;45(5):870-4.
1995: J Baniel; Richard S Foster; John P Donohue
Surgical anatomy of the lumbar vessels: implications for retroperitoneal surgery.
The Journal of urology 1995;153(5):1422-5.
1995: I Leibovitch; Richard S Foster; Thomas M Ulbright; John P Donohue
Adult primary pure teratoma of the testis. The Indiana experience.
Cancer 1995;75(9):2244-50.
1995: J Baniel; Richard S Foster; R Gonin; J E Messemer; John P Donohue; L H Einhorn
Late relapse of testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1170-6.
1995: J Baniel; Richard S Foster; R G Rowland; Richard Bihrle; John P Donohue
Complications of post-chemotherapy retroperitoneal lymph node dissection.
The Journal of urology 1995;153(3 Pt 2):976-80.
1995: Peter Albers; G A Miller; Attilio Orazi; Thomas M Ulbright; J Albers; John P Donohue; Richard S Foster
Immunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage A nonseminomatous testicular germ cell tumor at low risk for occult metastasis.
Cancer 1995;75(3):844-50.
1995: Richard Bihrle; Mark C Adams; Richard S Foster
Adaptations of the Mitrofanoff principle in adult continent urinary reservoirs.
Techniques in urology 1995;1(2):94-101.
1995: F J Fry; N T Sanghvi; Richard S Foster; Richard Bihrle; C Hennige
Ultrasound and microbubbles: their generation, detection and potential utilization in tissue and organ therapy--experimental.
Ultrasound in medicine & biology 1995;21(9):1227-37.
1995: C de Riese; W N Crabtree; W de Riese; J A Jones; J Pastor; Gerald Haupt; Richard S Foster; John P Donohue; Theodor Senge
Impact of the preparation technique on DNA content measured by image analysis in early stage human testis cancer.
International urology and nephrology 1995;27(5):603-13.
1995: Peter Albers; W T DeRiese; Thomas M Ulbright; John P Donohue; Richard S Foster
Prognostic factors in patients with pathological stage I non-seminomatous testicular germ cell tumors and tumor recurrence during follow-up.
Urological research 1995;23(4):211-3.
1995: John P Donohue; J A Thornhill; Richard S Foster; Richard Bihrle; R G Rowland; L H Einhorn
The role of retroperitoneal lymphadenectomy in clinical stage B testis cancer: the Indiana University experience (1965 to 1989).
The Journal of urology 1995;153(1):85-9.
1995: Peter Albers; J Albers; O W Cummings; M Boris; John P Donohue; Richard S Foster
Flow cytometric and cytophotometric DNA analysis cannot predict subsequent tumour recurrence in pathological stage IIA/B non-seminomatous testicular germ cell tumour patients who do not receive adjuvant chemotherapy.
European journal of cancer (Oxford, England : 1990) 1995;31A(5):848-9.
1994: John P Donohue; Richard S Foster
Management of retroperitoneal recurrences. Seminoma and nonseminoma.
The Urologic clinics of North America 1994;21(4):761-72.
1994: J S Little; Richard S Foster; Thomas M Ulbright; John P Donohue
Unusual neoplasms detected in testis cancer patients undergoing post-chemotherapy retroperitoneal lymphadenectomy.
The Journal of urology 1994;152(4):1144-9.
1994: Richard S Foster; A McNulty; L R Rubin; R Bennett; R G Rowland; G W Sledge; Richard Bihrle; John P Donohue
The fertility of patients with clinical stage I testis cancer managed by nerve sparing retroperitoneal lymph node dissection.
The Journal of urology 1994;152(4):1139-42; discussion 1142-3.
1994: W T de Riese; Peter Albers; E B Walker; Thomas M Ulbright; W N Crabtree; T Reister; Richard S Foster; John P Donohue
Predictive parameters of biologic behavior of early stage nonseminomatous testicular germ cell tumors.
Cancer 1994;74(4):1335-41.
1994: G R Wahle; Richard S Foster; Richard Bihrle; R G Rowland; R M Bennett; John P Donohue
Nerve sparing retroperitoneal lymphadenectomy after primary chemotherapy for metastatic testicular carcinoma.
The Journal of urology 1994;152(2 Pt 1):428-30.
1994: J Baniel; Richard S Foster; R G Rowland; Richard Bihrle; John P Donohue
Complications of primary retroperitoneal lymph node dissection.
The Journal of urology 1994;152(2 Pt 1):424-7.
1994: Richard S Foster; Richard Bihrle; N Sanghvi; John P Donohue
High-intensity focused ultrasound for the treatment of benign prostatic hypertrophy.
Seminars in urology 1994;12(3):200-4.
1994: W T De Riese; C De Riese; Thomas M Ulbright; E B Walker; J Messemer; J A Jones; T Reister; Peter Albers; E P Allhoff; Richard S Foster
Flow-cytometric and quantitative histologic parameters as prognostic indicators for occult retroperitoneal disease in clinical-stage-I non-seminomatous testicular germ-cell tumors.
International journal of cancer. Journal international du cancer 1994;57(5):628-33.
1994: Richard Bihrle; Richard S Foster; N T Sanghvi; John P Donohue; P J Hood
High intensity focused ultrasound for the treatment of benign prostatic hyperplasia: early United States clinical experience.
The Journal of urology 1994;151(5):1271-5.
1994: J Baniel; Richard Bihrle; G R Wahle; Richard S Foster
Splenic rupture during occlusion of the porta hepatis in resection of tumors with vena caval extension.
The Journal of urology 1994;151(4):992-4.
1994: Richard Bihrle; Richard S Foster; N T Sanghvi; F J Fry; John P Donohue
High-intensity focused ultrasound in the treatment of prostatic tissue.
Urology 1994;43(2 Suppl):21-6.
1994: J Baniel; J M Perez; Richard S Foster
Benign testicular tumor associated with Klinefelter's syndrome.
The Journal of urology 1994;151(1):157-8.
1994: J Baniel; Richard S Foster; R G Rowland; Richard Bihrle; John P Donohue
Complications of primary retroperitoneal lymph-node dissection for low-stage testicular cancer.
World journal of urology 1994;12(3):139-42.
1994: Richard S Foster; A McNulty; L R Rubin; R Bennett; R G Rowland; G W Sledge; Richard Bihrle; John P Donohue
Fertility considerations in nerve-sparing retroperitoneal lymph-node dissection.
World journal of urology 1994;12(3):136-8.
1994: Peter Albers; W deRiese; E B Walker; Thomas M Ulbright; W N Crabtree; T Reister; Richard S Foster; John P Donohue
Predictive parameters in biologic assessment of low-stage retroperitoneal lymph-node dissection.
World journal of urology 1994;12(3):120-4.
1994: Thomas M Ulbright; Attilio Orazi; W de Riese; C de Riese; J E Messemer; Richard S Foster; John P Donohue; J N Eble
The correlation of P53 protein expression with proliferative activity and occult metastases in clinical stage I non-seminomatous germ cell tumors of the testis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1994;7(1):64-8.
1994: W de Riese; E B Walker; C de Riese; Thomas M Ulbright; W N Crabtree; J Messemer; J A Jones; A Hinkel; Richard S Foster; John P Donohue
Quantitative DNA measurement by flow cytometry and image analysis of human nonseminomatous germ cell testicular tumors.
Urological research 1994;22(4):213-20.
1994: J S Little; Richard S Foster; Thomas M Ulbright; John P Donohue
Unusual neoplasms detected in testicular cancer patients undergoing postchemotherapy retroperitoneal lymphadenectomy.
World journal of urology 1994;12(4):200-6.
1994: John P Donohue; J A Thornhill; Richard S Foster; Richard Bihrle
Vascular considerations in postchemotherapy. Retroperitoneal lymph-node dissection: Part II.
World journal of urology 1994;12(4):187-9.
1994: John P Donohue; J A Thornhill; Richard S Foster; Richard Bihrle
Vascular considerations in postchemotherapy. Retroperitoneal lymph-node dissection: Part I--Vena cava.
World journal of urology 1994;12(4):182-6.
1994: John P Donohue; J A Thornhill; Richard S Foster; R G Rowland; Richard Bihrle
Stage I nonseminomatous germ-cell testicular cancer--management options and risk-benefit considerations.
World journal of urology 1994;12(4):170-6; discussion 177.
1994: Richard S Foster; Richard Bihrle; N T Sanghvi; John P Donohue; F J Fry
High intensity focused ultrasound treatment of human BPH.
Progress in clinical and biological research 1994;386():463-71.
1994: Richard S Foster; Richard Bihrle; J S Little; R G Rowland; John P Donohue
Stage II nonseminomatous germ-cell testicular tumors--the Indiana experience and risk-benefit analysis.
World journal of urology 1994;12(3):143-6; discussion 147.
1993: J Baniel; Richard S Foster; R G Rowland; Richard Bihrle; John P Donohue
Management of chylous ascites after retroperitoneal lymph node dissection for testicular cancer.
The Journal of urology 1993;150(5 Pt 1):1422-4.
1993: D W Hollensbe; Richard S Foster; C G Brito; K Kopecky
Percutaneous access to a continent urinary reservoir for removal of intravesical calculi: a case report.
The Journal of urology 1993;149(6):1546-7.
1993: John P Donohue; J A Thornhill; Richard S Foster; R G Rowland; Richard Bihrle
Primary retroperitoneal lymph node dissection in clinical stage A non-seminomatous germ cell testis cancer. Review of the Indiana University experience 1965-1989.
British journal of urology 1993;71(3):326-35.
1993: Richard S Foster; John P Donohue
Nerve-sparing retroperitoneal lymphadenectomy.
The Urologic clinics of North America 1993;20(1):117-25.
1993: John P Donohue; J A Thornhill; Richard S Foster; R G Rowland; Richard Bihrle
Retroperitoneal lymphadenectomy for clinical stage A testis cancer (1965 to 1989): modifications of technique and impact on ejaculation.
The Journal of urology 1993;149(2):237-43.
1993: Richard S Foster; R Bennett; Richard Bihrle; John P Donohue
A preliminary report: postoperative fertility assessment in nerve-sparing RPLND patients.
European urology 1993;23(1):165-7; discussion 168.
1993: Richard S Foster; Richard Bihrle; N T Sanghvi; F J Fry; John P Donohue
High-intensity focused ultrasound in the treatment of prostatic disease.
European urology 1993;23 Suppl 1():29-33.
1993: Richard S Foster; Richard Bihrle; N Sanghvi; F Fry; K Kopecky; J Regan; J Eble; C Hennige; L V Hennige; John P Donohue
Production of prostatic lesions in canines using transrectally administered high-intensity focused ultrasound.
European urology 1993;23(2):330-6.
1992: J S Little; Richard S Foster
Intra-abdominal desmoid tumor: an unusual case of recurrent tumor in a testis cancer patient.
The Journal of urology 1992;147(6):1619-21.
1992: Richard S Foster; John P Donohue
Surgical treatment of clinical stage A nonseminomatous testis cancer.
Seminars in oncology 1992;19(2):166-70.
1992: Mark C Adams; Richard Bihrle; Richard S Foster; C G Brito
Conversion of an ileal conduit to a continent catheterizable stoma.
The Journal of urology 1992;147(1):126-8.
1991: Richard Bihrle; L W Klee; Mark C Adams; Richard S Foster
Early clinical experience with the transverse colon-gastric tube continent urinary reservoir.
The Journal of urology 1991;146(3):751-3.
1991: John P Donohue; J A Thornhill; Richard S Foster; R G Rowland; Richard Bihrle
Resection of the inferior vena cava or intraluminal vena caval tumor thrombectomy during retroperitoneal lymph node dissection for metastatic germ cell cancer: indications and results.
The Journal of urology 1991;146(2):346-9.
1991: Richard S Foster; L R Rubin; A McNulty; Richard Bihrle; John P Donohue
Detection of antisperm-antibodies in patients with primary testicular cancer.
International journal of andrology 1991;14(3):179-85.
1991: Richard Bihrle; L W Klee; Mark C Adams; C P Steidle; Richard S Foster
Transverse colon-gastric tube composite reservoir.
Urology 1991;37(1):36-40.
1991: Richard S Foster; John P Donohue; Richard Bihrle
Stage A nonseminomatous testis carcinoma: rationale and results of nerve-sparing retroperitoneal lymphadenectomy.
Urologia internationalis 1991;46(3):294-7.
1990: Richard S Foster; J J Mulcahy; JT Callaghan; R Crabtree; D Brashear
Role of serum prolactin determination in evaluation of impotent patient.
Urology 1990;36(6):499-501.
1990: L W Klee; Mark C Adams; Richard S Foster
Ureteral stump transitional cell carcinoma in a patient with recurrent superficial bladder cancer: an argument for complete nephroureterectomy in selected patients.
The Journal of urology 1990;144(4):972-3.
1990: John P Donohue; Richard S Foster; R G Rowland; Richard Bihrle; J Jones; G Geier
Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation.
The Journal of urology 1990;144(2 Pt 1):287-91; discussion 291-2.
1990: N M Hockley; Richard S Foster; Richard Bihrle; C P Steidle; K K Kopecky
Use of magnetic resonance imaging to determine surgical approach to renal cell carcinoma with vena caval extension.
Urology 1990;36(1):55-60.
1990: D M Scheidler; Richard S Foster; Richard Bihrle; J W Scott; S E Litwiller
Anastomotic suture granuloma following radical retropubic prostatectomy.
The Journal of urology 1990;143(1):133-4.
1989: Richard Bihrle; C G Brito; Mark C Adams; P W Woodbury; Richard S Foster
Construction of an antirefluxing urinary conduit using a plicated ileocecal segment.
The Journal of urology 1989;142(6):1567-9.
1989: Richard Bihrle; Richard S Foster; C P Steidle; Mark C Adams; P W Woodbury; G P Sutton; A McNulty
Creation of a transverse colon--gastric composite reservoir: a new technique.
The Journal of urology 1989;141(5):1217-20.
1988: Richard S Foster; Yousuf Mahomed; Richard Bihrle; S Strup
Use of a caval-atrial shunt for resection of a caval tumor thrombus in renal cell carcinoma.
The Journal of urology 1988;140(6):1370-1.
1988: Richard Bihrle; John P Donohue; Richard S Foster
Complications of retroperitoneal lymph node dissection.
The Urologic clinics of North America 1988;15(2):237-42.
1988: C G Brito; T Bloch; Richard S Foster; Richard Bihrle
Testicular papillary cystadenomatous tumor of low malignant potential: a case report and discussion of the literature.
The Journal of urology 1988;139(2):378-9.